CNS Disorders  >>  iloperidone  >>  Phase 2
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
iloperidone / Generic mfg.
NCT01623713: Efficacy and Safety Study of Iloperidone Virus Risperidone to Treat Schizophrenia

Completed
2
260
RoW
iloperidone, Risperidone
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Schizophrenia, Iloperidone, Efficacy
10/13
11/13
NCT01917318: Iloperidone for Symptoms of Arousal in Post Traumatic Stress Disorder (PTSD)

Terminated
2
1
US
Iloperidone, Fanapt, Fanapta, Zomaril, Placebo, Sugar pill
University of Colorado, Denver, Novartis Pharmaceuticals
Post Traumatic Stress Disorder
02/14
02/14
NCT03319953: A Randomized, Double-Blind, Placebo Controlled, Two-Period Cross-Over, Proof of Activity Study to Evaluate the Effects of TAK-041 on Motivational Anhedonia as Add-On to Antipsychotics in Participants With Stable Schizophrenia

Completed
2
23
Europe
TAK-041, Placebo, Second Generation Antipsychotics (SGA)
Neurocrine Biosciences, Takeda
Stable Schizophrenia
09/19
11/19
NCT05344365: A Study to Evaluate Iloperidone for the Treatment of Parkinson's Disease Psychosis

Withdrawn
2
24
US
Iloperidone, VYV-683, FANAPT
Vanda Pharmaceuticals
Parkinson Disease Psychosis
11/23
11/23
NCT01348100: Safety, Tolerability, and Pharmacokinetics of Iloperidone Depot in Schizophrenic Patients

Completed
1/2
81
US
Iloperidone crystalline formulation, Iloperidone microparticle formulation, Oral iloperidone
Novartis Pharmaceuticals, Vanda Pharmaceuticals
Schizophrenia
07/12
07/12

Download Options